148 related articles for article (PubMed ID: 31811797)
21. GTPase splice variants RAC1 and RAC1B display isoform-specific differences in localization, prenylation, and interaction with the chaperone protein SmgGDS.
Koehn OJ; Lorimer E; Unger B; Harris R; Das AS; Suazo KF; Auger SA; Distefano MD; Prokop JW; Williams CL
J Biol Chem; 2023 Jun; 299(6):104698. PubMed ID: 37059183
[TBL] [Abstract][Full Text] [Related]
22. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
[TBL] [Abstract][Full Text] [Related]
23. The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.
Kotelevets L; Walker F; Mamadou G; Lehy T; Jordan P; Chastre E
Oncogene; 2018 Nov; 37(46):6054-6068. PubMed ID: 29985482
[TBL] [Abstract][Full Text] [Related]
24. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation.
Singh A; Karnoub AE; Palmby TR; Lengyel E; Sondek J; Der CJ
Oncogene; 2004 Dec; 23(58):9369-80. PubMed ID: 15516977
[TBL] [Abstract][Full Text] [Related]
25. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
[TBL] [Abstract][Full Text] [Related]
26. Increased Rac1b expression sustains colorectal tumor cell survival.
Matos P; Jordan P
Mol Cancer Res; 2008 Jul; 6(7):1178-84. PubMed ID: 18644982
[TBL] [Abstract][Full Text] [Related]
27. Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.
Pelisch F; Khauv D; Risso G; Stallings-Mann M; Blaustein M; Quadrana L; Radisky DC; Srebrow A
J Cell Biochem; 2012 Jul; 113(7):2319-29. PubMed ID: 22345078
[TBL] [Abstract][Full Text] [Related]
28. Antagonistic effects of RAC1 and tumor-related RAC1b on NIS expression in thyroid.
Faria M; Félix D; Domingues R; Bugalho MJ; Matos P; Silva AL
J Mol Endocrinol; 2019 Nov; 63(4):309-320. PubMed ID: 31590142
[TBL] [Abstract][Full Text] [Related]
29. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process.
Visvikis O; Lorès P; Boyer L; Chardin P; Lemichez E; Gacon G
FEBS J; 2008 Jan; 275(2):386-96. PubMed ID: 18093184
[TBL] [Abstract][Full Text] [Related]
30. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms.
Esufali S; Charames GS; Bapat B
FEBS Lett; 2007 Oct; 581(25):4850-6. PubMed ID: 17888911
[TBL] [Abstract][Full Text] [Related]
31. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors.
Jordan P; Brazåo R; Boavida MG; Gespach C; Chastre E
Oncogene; 1999 Nov; 18(48):6835-9. PubMed ID: 10597294
[TBL] [Abstract][Full Text] [Related]
32. Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition.
Huang YT; Hsu YT; Wu PY; Yeh YM; Lin PC; Hsu KF; Shen MR
J Exp Clin Cancer Res; 2024 Mar; 43(1):65. PubMed ID: 38424547
[TBL] [Abstract][Full Text] [Related]
33. RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells.
Faria M; Matos P; Pereira T; Cabrera R; Cardoso BA; Bugalho MJ; Silva AL
PLoS One; 2017; 12(2):e0172689. PubMed ID: 28234980
[TBL] [Abstract][Full Text] [Related]
34. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
35. Rac1 signaling modulates BCL-6-mediated repression of gene transcription.
Barros P; Jordan P; Matos P
Mol Cell Biol; 2009 Aug; 29(15):4156-66. PubMed ID: 19487462
[TBL] [Abstract][Full Text] [Related]
36. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
Geng F; Jiang Z; Song X; Zhou H; Zhao H
Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
[TBL] [Abstract][Full Text] [Related]
37. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
[TBL] [Abstract][Full Text] [Related]
38. Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
Chen QY; Zheng Y; Jiao DM; Chen FY; Hu HZ; Wu YQ; Song J; Yan J; Wu LJ; Lv GY
J Nutr Biochem; 2014 Feb; 25(2):177-85. PubMed ID: 24445042
[TBL] [Abstract][Full Text] [Related]
39. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]